These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 803512)

  • 1. Disappearance of plasma growth hormone in acromegaly and protein-calorie malnutrition after somatostatin.
    Pimstone BL; Becker D; Kronheim S
    J Clin Endocrinol Metab; 1975 Jan; 40(1):168-71. PubMed ID: 803512
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of synthetic somatostatin in normal and acromegalic males].
    Wiegelmann W; Solbach HG; Kley HK; Rudorff KH; Herrmann J; Zimmermann H; Krüskemper HL
    Dtsch Med Wochenschr; 1975 Feb; 100(8):331-4. PubMed ID: 1090428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum growth hormone responses to thyrotrophin releasing hormone in children with protein-calorie malnutrition.
    Becker D; Kronheim S; Pimstone B
    Horm Metab Res; 1975 Jul; 7(4):358-9. PubMed ID: 807511
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Somatostatin (somatotrophin release inhibiting factor).
    S Afr Med J; 1974 Jun; 48(28):1180. PubMed ID: 4599981
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of somatostatin to suppress thyrotropin releasing factor and luteinizing hormone releasing factor-induced growth hormone release in acromegaly.
    Giustina G; Reschini E; Peracchi M; Cantalamessa L; Cavagnini F; Pinto M; Bulgheroni P
    J Clin Endocrinol Metab; 1974 May; 38(5):906-9. PubMed ID: 4207370
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone secretion in protein-calorie malnutrition.
    Raghuramulu N; Rao KS
    J Clin Endocrinol Metab; 1974 Feb; 38(2):176-80. PubMed ID: 4204726
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Growth hormone in acromegaly.
    Lancet; 1973 Oct; 2(7834):913. PubMed ID: 4126954
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in endocrinology. Somatostatin. New hypothalamic hormone inhibiting the secretion of the growth hormone].
    Sliwowski A
    Pol Arch Med Wewn; 1975 Mar; 53(3):287-91. PubMed ID: 1089961
    [No Abstract]   [Full Text] [Related]  

  • 10. Growth hormone levels in protein calorie malnutrition.
    Samuel AM; Deshpande UR
    J Clin Endocrinol Metab; 1972 Dec; 35(6):863-7. PubMed ID: 4628866
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Somatostatin: newcomer from the hypothalamus.
    Brazeau P; Gullemin R
    N Engl J Med; 1974 Apr; 290(17):963-4. PubMed ID: 4206096
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
    Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH
    N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408
    [No Abstract]   [Full Text] [Related]  

  • 13. The suppression of blood growth hormone level by somatostatin infusion in patients with active acromegaly.
    Kwok CF; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Oct; 42(4):249-54. PubMed ID: 2907415
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of hypothalamic surgery and somatostatin on chlorpromazine-induced growth hormone release in rats.
    Kato Y; Chihara K; Ogo S; Imura H
    Endocrinology; 1974 Dec; 95(6):1608-13. PubMed ID: 4611745
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly.
    Pieters GF; Romeijn JE; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 May; 54(5):942-8. PubMed ID: 6120951
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Effect of growth hormone release inhibiting hormone on the release of growth hormone and other pituitary hormones in man.
    Schally AV; Coy DM; Kastin AJ; Tunbridge WM; Evered DC; Weightman D; Hall R; Besser GM; Goldie DJ; McNeilly AS; Mortimer CH; Phenekos C
    J Endocrinol; 1974 Apr; 61(1):XIV. PubMed ID: 4208301
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unaltered plasma GH levels in acromegalics and normal men and women after administration of (Pyro)Glu-Ser-Gly-NH2, a proposed GH-releasing hormone.
    Gonzalez-Barcena D; Kastin AJ; Coy DH; Glick S; Schalch DS; Lee LA; Arzac JP; Schally AV
    J Clin Endocrinol Metab; 1974 Jun; 38(6):1134-6. PubMed ID: 4831709
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M; Williams TC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition.
    Hintz RL; Suskind R; Amatayakul K; Thanangkul O; Olson R
    J Pediatr; 1978 Jan; 92(1):153-6. PubMed ID: 412936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.